BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38902589)

  • 1. The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion.
    Szeimies RM; Ulrich C; Ferrándiz-Pulido C; Hofbauer GFL; Lear JT; Lebbé C; Piaserico S; Hædersdal M
    Dermatol Ther (Heidelb); 2024 Jun; ():. PubMed ID: 38902589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project.
    Morton C; Baharlou S; Basset-Seguin N; Calzavara-Pinton P; Dirschka T; Gilaberte Y; Haedersdal M; Hofbauer G; Sapra S; Waalboer-Spuij R; Yip L; Szeimies RM
    Acta Derm Venereol; 2023 Jun; 103():adv6229. PubMed ID: 37289027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeam™ of expert clinicians.
    Richard MA; Amici JM; Basset-Seguin N; Claudel JP; Cribier B; Dreno B
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):339-346. PubMed ID: 29235161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis.
    Berman B; Ablon GR; Bhatia ND; Ceilley RI; Goldberg DJ; Nestor MS; Weinkle SH
    J Drugs Dermatol; 2017 Mar; 16(3):260-264. PubMed ID: 28301622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actinic Keratosis in Solid Organ Transplant Recipients: A Medical Literature Review.
    Morelló Vicente A; Oteiza Rius I; Aguado Gil L
    Actas Dermosifiliogr; 2024 Apr; 115(4):368-373. PubMed ID: 37925069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report.
    Rosso JD; Armstrong AW; Berman B; Bhatia N; Cockerell C; Goldenberg G; Kirby J; Lebwohl M; Stein Gold L; Marson JW; Rigel DS
    J Drugs Dermatol; 2021 Aug; 20(8):888-893. PubMed ID: 34397199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.
    Werner RN; Stockfleth E; Connolly SM; Correia O; Erdmann R; Foley P; Gupta AK; Jacobs A; Kerl H; Lim HW; Martin G; Paquet M; Pariser DM; Rosumeck S; Röwert-Huber HJ; Sahota A; Sangueza OP; Shumack S; Sporbeck B; Swanson NA; Torezan L; Nast A; ;
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2069-79. PubMed ID: 26370093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-centered management of actinic keratosis. Results of a multi-center clinical consensus analyzing non-melanoma skin cancer patient profiles and field-treatment strategies.
    Philipp-Dormston WG; Battistella M; Boussemart L; Di Stefani A; Broganelli P; Thoms KM
    J Dermatolog Treat; 2020 Sep; 31(6):576-582. PubMed ID: 31625770
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
    Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
    Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.
    Dréno B; Amici JM; Basset-Seguin N; Cribier B; Claudel JP; Richard MA;
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1141-9. PubMed ID: 24612407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines of care for the management of actinic keratosis: Executive summary.
    Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE
    J Am Acad Dermatol; 2021 Oct; 85(4):945-955. PubMed ID: 34111497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines of care for the management of actinic keratosis.
    Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE
    J Am Acad Dermatol; 2021 Oct; 85(4):e209-e233. PubMed ID: 33820677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
    Noels EC; Hollestein LM; van Egmond S; Lugtenberg M; van Nistelrooij LPJ; Bindels PJE; van der Lei J; Stern RS; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Sep; 181(3):544-553. PubMed ID: 30636037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT.
    Calzavara-Pinton P; Hædersdal M; Barber K; Basset-Seguin N; Del Pino Flores ME; Foley P; Galimberti G; Gerritsen R; Gilaberte Y; Ibbotson S; Peris K; Sapra S; Sotiriou E; Torezan L; Ulrich C; Guillemot J; Hendrich J; Szeimies RM
    J Cutan Med Surg; 2017; 21(1_suppl):3S-16S. PubMed ID: 28406719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
    Stockfleth E; Bastian M
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists.
    Noels EC; Lugtenberg M; van Egmond S; Droger SM; Buis PAJ; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Jul; 181(1):96-104. PubMed ID: 30801664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and clinical practice of multiple face and scalp actinic keratosis in France.
    Savary J; Tine MC; Weber AC; Dorey J
    J Mark Access Health Policy; 2019; 7(1):1605787. PubMed ID: 31143416
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient satisfaction and reported outcomes on the management of actinic keratosis.
    Khanna R; Bakshi A; Amir Y; Goldenberg G
    Clin Cosmet Investig Dermatol; 2017; 10():179-184. PubMed ID: 28553130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis.
    Stockfleth E; Bégeault N; Delarue A
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):467-479. PubMed ID: 34954811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
    Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
    Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.